YY1/circCTNNB1/miR-186-5p/YY1 positive loop aggravates lung cancer progression through the Wnt pathway. | YY1/circCTNNB1/miR-186-5p/YY1 positive loop aggravates lung cancer progression through the Wnt pathway. Shen Y, Yang Y, Zhao Y, Nuerlan S, Zhan Y, Liu C., Free PMC Article | 07/11/2024 |
Up-regulation of lncRNA WT1-AS ameliorates Abeta-stimulated neuronal injury through modulation of miR-186-5p/CCND2 axis in Alzheimer's disease. | Up-regulation of lncRNA WT1-AS ameliorates Aβ-stimulated neuronal injury through modulation of miR-186-5p/CCND2 axis in Alzheimer's disease. Tang Y, Zhang X, Wang S, Liu L, Wang Q, Liu Y, Yu Y, Zhai Q. | 03/21/2024 |
Splicing factor ESRP1 derived circ_0068162 promotes the progression of oral squamous cell carcinoma via the miR-186/JAG axis. | Splicing factor ESRP1 derived circ_0068162 promotes the progression of oral squamous cell carcinoma via the miR-186/JAG axis. Chen S, Zong Y, Hou Z, Deng Z, Xia Z. | 03/12/2024 |
miR-186-5p regulates the inflammatory response of chronic obstructive pulmonary disorder by targeting HIF-1alpha. | miR‑186‑5p regulates the inflammatory response of chronic obstructive pulmonary disorder by targeting HIF‑1α. Fu Y, Zhao J, Chen J, Zheng Y, Mo R, Zhang L, Zhang B, Lin Q, He C, Li S, Lin L, Xie T, Ding Y., Free PMC Article | 02/6/2024 |
LncRNA PSMA3-AS1 activates the progression of triple-negative breast cancer cells by blocking miR-186-5p-mediated PSME3 inhibition. | LncRNA PSMA3-AS1 activates the progression of triple-negative breast cancer cells by blocking miR-186-5p-mediated PSME3 inhibition. Peng M, Yuan H. | 02/1/2024 |
miR-186 regulates epithelial-mesenchymal transformation to promote nasopharyngeal carcinoma metastasis by targeting ZEB1. | miR-186 regulates epithelial-mesenchymal transformation to promote nasopharyngeal carcinoma metastasis by targeting ZEB1. Tang L, Xiang Y, Zhou J, Li T, Jia T, Du G., Free PMC Article | 01/30/2024 |
Clonal variability in chromosomal instability as a potential driver in the acquisition of tumorigenic phenotype in chronic arsenic-exposed and hsa-miR-186 overexpressing human keratinocytes. | Clonal variability in chromosomal instability as a potential driver in the acquisition of tumorigenic phenotype in chronic arsenic-exposed and hsa-miR-186 overexpressing human keratinocytes. Lykoudi A, Ferragut Cardoso AP, Wise SS, Banerjee M, States JC., Free PMC Article | 11/10/2023 |
METTL3-mediated m[6]A modification of lncRNA SNHG3 accelerates gastric cancer progression by modulating miR-186-5p/cyclinD2 axis. | METTL3-mediated m(6)A modification of lncRNA SNHG3 accelerates gastric cancer progression by modulating miR-186-5p/cyclinD2 axis. Ji G, Wang X, Xi H., Free PMC Article | 11/3/2023 |
CD8 T Cell-Derived Exosomal miR-186-5p Elicits Renal Inflammation via Activating Tubular TLR7/8 Signal Axis. | CD8 T Cell-Derived Exosomal miR-186-5p Elicits Renal Inflammation via Activating Tubular TLR7/8 Signal Axis. Xu X, Qu S, Zhang C, Zhang M, Qin W, Ren G, Bao H, Li L, Zen K, Liu Z., Free PMC Article | 09/29/2023 |
miRNA-186-5p inhibits migration, invasion and proliferation of breast cancer cells by targeting SBEM. | miRNA-186-5p inhibits migration, invasion and proliferation of breast cancer cells by targeting SBEM. Hao H, Wang B, Yang L, Sang Y, Xu W, Liu W, Zhang L, Jiang D., Free PMC Article | 08/7/2023 |
Hsa_circ_0005085 may suppress cutaneous squamous cell carcinoma growth and metastasis through targeting the miR-186-5p/LAMC1 axis. | Hsa_circ_0005085 may suppress cutaneous squamous cell carcinoma growth and metastasis through targeting the miR-186-5p/LAMC1 axis. Wang L, Liu Y, Gao Q, Hu R., Free PMC Article | 06/29/2023 |
MicroRNA-186 suppresses cell proliferation and metastasis in bladder cancer. | MicroRNA-186 suppresses cell proliferation and metastasis in bladder cancer. Liang JF, Li PH, Zhu Y, Zheng SS, Liu JW, Song SQ., Free PMC Article | 05/4/2023 |
LncRNA NUTM2A-AS1 aggravates the progression of hepatocellular carcinoma by activating the miR-186-5p/KLF7-mediated Wnt/beta-catenin pathway. | LncRNA NUTM2A-AS1 aggravates the progression of hepatocellular carcinoma by activating the miR-186-5p/KLF7-mediated Wnt/beta-catenin pathway. Long J, Liu L, Yang X, Zhou X, Lu X, Qin L. | 01/21/2023 |
miR-186-5p Dysregulation in Serum Exosomes from Patients with AMI Aggravates Atherosclerosis via Targeting LOX-1. | miR-186-5p Dysregulation in Serum Exosomes from Patients with AMI Aggravates Atherosclerosis via Targeting LOX-1. Ding J, Li H, Liu W, Wang X, Feng Y, Guan H, Chen Z., Free PMC Article | 12/31/2022 |
SNHG1/miR-186/FUT8 regulates cell migration and invasion in oral squamous cell carcinoma. | SNHG1/miR-186/FUT8 regulates cell migration and invasion in oral squamous cell carcinoma. Zhao Y, Shi J, Zhao Y, Lu Z. | 12/24/2022 |
Regulation of IGF2BP1 by miR-186 and its impact on downstream lncRNAs H19, FOXD2-AS1, and SNHG3 in HCC. | Regulation of IGF2BP1 by miR-186 and its impact on downstream lncRNAs H19, FOXD2-AS1, and SNHG3 in HCC. Habashy DA, Hamad MHM, Ragheb M, Khalil ZA, El Sobky SA, Hosny KA, Esmat G, El-Ekiaby N, Fawzy IO, Abdelaziz AI. | 11/19/2022 |
METTL3/LINC00662/miR-186-5p feedback loop regulates docetaxel resistance in triple negative breast cancer. | METTL3/LINC00662/miR-186-5p feedback loop regulates docetaxel resistance in triple negative breast cancer. Jing L, Lan L, Mingxin Z, Zhaofeng Z., Free PMC Article | 10/15/2022 |
MiR-223 and MiR-186 Are Associated with Long-Term Mortality after Myocardial Infarction. | MiR-223 and MiR-186 Are Associated with Long-Term Mortality after Myocardial Infarction. Elbaz M, Faccini J, Laperche C, Grazide MH, Ruidavets JB, Vindis C., Free PMC Article | 10/8/2022 |
Knockdown circZNF131 Inhibits Cell Progression and Glycolysis in Gastric Cancer Through miR-186-5p/PFKFB2 Axis. | Knockdown circZNF131 Inhibits Cell Progression and Glycolysis in Gastric Cancer Through miR-186-5p/PFKFB2 Axis. Shen X, Zhu X, Hu P, Ji T, Qin Y, Zhu J. | 09/24/2022 |
Circular RNA circSEPT9 Is Upregulated in Endometrial Cancer and Promotes Cell Invasion and Migration by Downregulating miR-186 through Methylation. | Circular RNA circSEPT9 Is Upregulated in Endometrial Cancer and Promotes Cell Invasion and Migration by Downregulating miR-186 through Methylation. Guo X, Zeng Y, Ye G, Yang J, Wu Q, Shi Y, Lu R. | 07/23/2022 |
Hsa_circRNA_0001971 contributes to oral squamous cell carcinoma progression via miR-186-5p/Fibronectin type III domain containing 3B axis. | Hsa_circRNA_0001971 contributes to oral squamous cell carcinoma progression via miR-186-5p/Fibronectin type III domain containing 3B axis. Zhang J, Peng Y, Jiang S, Li J., Free PMC Article | 07/16/2022 |
OxLDL-stimulated macrophage exosomes promote proatherogenic vascular smooth muscle cell viability and invasion via delivering miR-186-5p then inactivating SHIP2 mediated PI3K/AKT/mTOR pathway. | OxLDL-stimulated macrophage exosomes promote proatherogenic vascular smooth muscle cell viability and invasion via delivering miR-186-5p then inactivating SHIP2 mediated PI3K/AKT/mTOR pathway. Ren L, Chen S, Yao D, Yan H. | 05/21/2022 |
miR-186-5p inhibits the progression of oral squamous cell carcinoma by targeting ITGA6 to impair the activity of the PI3K/AKT pathway. | miR-186-5p inhibits the progression of oral squamous cell carcinoma by targeting ITGA6 to impair the activity of the PI3K/AKT pathway. Chen M, Zhang J. | 04/30/2022 |
M2 Macrophage Derived Extracellular Vesicle-Mediated Transfer of MiR-186-5p Promotes Colon Cancer Progression by Targeting DLC1. | M2 Macrophage Derived Extracellular Vesicle-Mediated Transfer of MiR-186-5p Promotes Colon Cancer Progression by Targeting DLC1. Guo J, Wang X, Guo Q, Zhu S, Li P, Zhang S, Min L., Free PMC Article | 04/23/2022 |
MicroRNA profiling identifies Forkhead box transcription factor M1 (FOXM1) regulated miR-186 and miR-200b alterations in triple negative breast cancer. | MicroRNA profiling identifies Forkhead box transcription factor M1 (FOXM1) regulated miR-186 and miR-200b alterations in triple negative breast cancer. Hamurcu Z, Sener EF, Taheri S, Nalbantoglu U, Kokcu ND, Tahtasakal R, Cınar V, Guler A, Ozkul Y, Dönmez-Altuntas H, Ozpolat B. | 01/22/2022 |